- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
13 result(s) found for: Prevalence of mental disorders.
Displaying page 1 of 1.
EudraCT Number: 2007-004009-93 | Sponsor Protocol Number: 12118A | Start Date*: 2008-05-20 | |||||||||||
Sponsor Name:LUNDBECK ITALIA | |||||||||||||
Full Title: Prevalence of depression,anxiety and impulse control disorder (ICD) in patients with Parkinson's disease and effectiveness of escitalopram | |||||||||||||
Medical condition: Depression, anxiety and ICD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005078-25 | Sponsor Protocol Number: CHUBX2019/59 | Start Date*: 2023-01-25 |
Sponsor Name:CHU de Bordeaux | ||
Full Title: Phase III randomized, multicenter open label study to evaluate the efficacy of immunomodulatory therapy in case of psychiatric disorders with proven dysimmunity. | ||
Medical condition: Mental and behavioral disorders (F00-F99) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000069-57 | Sponsor Protocol Number: P15-01 | Start Date*: 2017-07-21 | |||||||||||
Sponsor Name:BIOPROJET PHARMA | |||||||||||||
Full Title: A Multisite Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment | |||||||||||||
Medical condition: Male or female with moderate or severe DSM-5 alcohol use disorder (based on the alcohol use disorders section of MINI) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003597-18 | Sponsor Protocol Number: 18F-AV-45-010 | Start Date*: 2009-05-28 | |||||||||||
Sponsor Name:Avid Radiopharmaceuticals, Inc | |||||||||||||
Full Title: A study evaluating the imaging characteristics of 18F-AV-45 in patients with frontotemporal dementia compared to patients with Alzheimer's disease and normal controls | |||||||||||||
Medical condition: Use of 18F-AV-45 positron emission tomography as early diagnostic technique in frontal lobe dementia and Alzheimer's disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006099-38 | Sponsor Protocol Number: P-piller102 | Start Date*: 2012-08-06 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Effects of an antiandrogenic oral contraceptive on eating behaviour in women with bulimia – A randomized double blinded, placebo controlled study. | ||
Medical condition: Bulimia nervosa is an eating disorder with a prevalence of about 2% in young women (Fairburn and Beglin, 1990). It is characterized by frequent binge eating episodes and the regular use of inapprop... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020185-19 | Sponsor Protocol Number: KP7242114 | Start Date*: 2011-05-30 | ||||||||||||||||
Sponsor Name:University Medical Center Utrecht | ||||||||||||||||||
Full Title: Optimization of Treatment and Management of Schizophrenia in Europe | ||||||||||||||||||
Medical condition: Schizophrenia ICD-10 code F20 or schizophreniform disorder ICD-10 code F23.1 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) GB (Completed) ES (Prematurely Ended) NL (Prematurely Ended) CZ (Completed) DK (Prematurely Ended) AT (Completed) BE (Completed) IT (Completed) BG (Completed) RO (Suspended by CA) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000207-90 | Sponsor Protocol Number: P15-14/BF2.649 | Start Date*: 2016-11-24 | |||||||||||
Sponsor Name:BIPROJET PHARMA | |||||||||||||
Full Title: A Multisite Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Pitolisant (BF2.649) For Alcohol Use Disorder Treatment. | |||||||||||||
Medical condition: Patients with moderate to severe alcohol use disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-024119-15 | Sponsor Protocol Number: rs4680-tolcapona | Start Date*: 2014-04-10 | |||||||||||
Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra | |||||||||||||
Full Title: EVALUATION OF THE EFFICACY OF TOLCAPONE AS A GENOTYPE-BASED TARGETED COGNITIVE ENHANCER IN SCHIZOPHRENIA, BASED ON THE POLYMORPHISM RS4680 | |||||||||||||
Medical condition: Esquizofrenia crónica controlada. (10 pacientes con el genotipo val/val y 10 pacientes con el genotipo met/met) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000766-42 | Sponsor Protocol Number: WN42171 | Start Date*: 2020-07-23 | ||||||||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | ||||||||||||||||||
Full Title: AN OPEN-LABEL, MULTICENTER, ROLLOVER STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF LONG-TERM GANTENERUMAB ADMINISTRATION IN PARTICIPANTS WITH ALZHEIMER'S DISEASE | ||||||||||||||||||
Medical condition: Alzheimer's Disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DK (Completed) PT (Prematurely Ended) PL (Prematurely Ended) HU (Completed) DE (Completed) FR (Completed) IT (Prematurely Ended) LT (Completed) NL (Completed) BE (Completed) FI (Completed) HR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-005017-12 | Sponsor Protocol Number: EyeADHD-01 | Start Date*: 2014-03-31 | |||||||||||
Sponsor Name:Parnassia Bavo Groep - PsyQ | |||||||||||||
Full Title: Looking into the eye of ADHD. Investigating the relationship between ADHD, the delayed circadian rhythm and the functioning of the eye. | |||||||||||||
Medical condition: Adults with ADHD and suboptimal eye functioning. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006609-25 | Sponsor Protocol Number: MOOD-HF | Start Date*: 2008-05-27 | |||||||||||
Sponsor Name:Julius Maximilians Universität Würzburg | |||||||||||||
Full Title: Effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in Depressed Heart Failure patients | |||||||||||||
Medical condition: To investigate the effects of selective serotonin re-uptake inhibition with the SSRI escitalopram on morbidity and mortality in depressed patients with CHF. The primary endpoint is the time to a fi... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022914-15 | Sponsor Protocol Number: A3051123 | Start Date*: 2012-03-01 | |||||||||||
Sponsor Name:Pfizer, S.L.U. | |||||||||||||
Full Title: A PHASE 4, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO -CONTROLLED, MULTICENTER STUDY EVALUATING THE NEUROPSYCHIATRIC SAFETY AND EFFICACY OF 12 WEEKS VARENICLINE TARTRATE 1MG BID AND BUPROPION HYD... | |||||||||||||
Medical condition: Nicotine Addiction with the desire to quit smoking | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Completed) DK (Completed) FI (Completed) BG (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000547-27 | Sponsor Protocol Number: CTIMPMCRENAL12 | Start Date*: 2012-11-01 | |||||||||||||||||||||
Sponsor Name:East and North Hertfordshire NHS Trust [...] | |||||||||||||||||||||||
Full Title: A Pilot Randomised Controlled Trial of Drug Treatment for Depression in Patients undergoing Haemodialysis | |||||||||||||||||||||||
Medical condition: Major Depressive Disorder in Patients with End Stage Renal Disease | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
